Focused
n the few to heal the many
We are committed to develop new treatments against diseases rooted in accelerated aging. By combining massive genomic sequencing and AI treatment of data, we can generate innovative compounds, able to slow down or stop cell senescence, oxidative stress.
Targeting Telomere Stability to Counteract Accelerated Aging and Disease
Rebuilding Health by Repairing Cellular Time
We are a biomedical company developing a new generation of drugs designed to slow or reverse diseases caused by accelerated aging. At the heart of our innovation is a focus on telomeres—the protective caps on our chromosomes that act as the body’s molecular clock. When telomeres shorten too quickly, cells age prematurely, leading to conditions such as idiopathic pulmonary fibrosis, bone marrow failure, diabetes, and neurodegenerative disorders.
Our mission is to restore telomere stability, helping cells regain normal function and extend healthy human lifespan, and in doing so, lower oxidative stress, accumulation od DNA damage, and inflammation. To achieve this, we use a cutting-edge combination of artificial intelligence, comparative genomics, and molecular biology.
Lab diagnostics
We offer advanced tests and precise results for healthcare needs.
Research-driven care
Our goal is to support better health with science and insight.
Pharma expertise
We lead in lab testing, drug delivery, and research work.
Trusted solutions
We improve lives with precise lab and pharma support.
From Comparative Biology to Precision Telomere Therapeutics
The Science Behind Innovation
Every species on Earth has evolved a unique balance between telomere maintenance and lifespan. Some, like whales or bats, maintain long, stable telomeres for decades, while others lose them quickly. These differences contain vital clues about cellular longevity.
Our proprietary AI platform analyzes telomerase and shelterin gene sequences—the key components responsible for maintaining telomeres—across a wide range of species, including humans. By correlating genetic variations with telomere length and lifespan, the system identifies the most promising genetic patterns for improving telomere stability in human cells.
These insights allow us to model and select the best combinations of telomerase and shelterin genetic variants. We then test them in laboratory models of diseases driven by telomere dysfunction, including diabetes, ataxia-telangiectasia, idiopathic pulmonary fibrosis, and bone marrow failure syndromes. In doing so, we discover the precise molecular mechanisms that restore healthy cellular replication.
Engineering Drug Candidates That Restore Telomere Function
From Genes to Therapies
Once we identify which genetic variants stabilize telomeres most effectively, we translate that knowledge into practical therapeutics. Our scientists generate small bioactive peptides and also design small molecules that mimic the beneficial effects of these genetic changes but can be delivered safely and efficiently as drugs.
We first test these compounds in sick human cells. If a molecule successfully restores telomere length and cellular health then, it moves on to testing in animal models that suffer the same human disease. When we see clear disease reversal in animals, the compound advances to preclinical safety studies, where we evaluate toxicity, pharmacokinetics, stability, and tissue distribution. From here, they enter clinical studies and, if still successful, they will reach our patients.
Leading research
Our team offers custom lab and drug services tailored just for you.
Trusted methods
We provide lab and pharma support that improves patient and research results.
See what our clients say
A New Class of Medicine industry
Pharma provided accurate results and expert advice for our lab needs. Their team was caring, skilled, and helped us improve patient care outcomes.
Dr. Helen White
Boston, MA
Pharma improved our workflow with timely lab results and reliable service. Their experts made a difference in our work with their support and care.
Dr. Kevin Adams
Cambridge, MA
Pharma’s laboratory and research solutions boosted our clinical projects. Their skilled team made a true impact on our progress.
Linda Grant
Providence, RI
A New Class of Medicine
Laboratory diagnostics & testing
By directly targeting the molecular engines of aging, we are pioneering therapies that do more than treat symptoms—they correct the root causes of age-related decline. Our vision is a future where accelerated age-linked diseases can be slowed, halted, or even reversed, enabling people to live healthier, longer lives.
Common Questions
Have inquiries? Reach out to us!
A place where science and care shape every advance
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

